{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T05:46:24Z","timestamp":1747374384179},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,12,19]],"date-time":"2012-12-19T00:00:00Z","timestamp":1355875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1007\/s10014-012-0127-8","type":"journal-article","created":{"date-parts":[[2012,12,18]],"date-time":"2012-12-18T07:38:23Z","timestamp":1355816303000},"page":"23-30","source":"Crossref","is-referenced-by-count":19,"title":["Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma"],"prefix":"10.1007","volume":"31","author":[{"given":"Yasutaka","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Mohri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishie","family":"Tanino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Terasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,12,19]]},"reference":[{"key":"127_CR1","doi-asserted-by":"crossref","unstructured":"Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56\u201360; discussion 60","DOI":"10.1227\/01.NEU.0000330399.55586.63"},{"key":"127_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11910-009-0034-5","volume":"9","author":"AD Norden","year":"2009","unstructured":"Norden AD, Drappatz J, Wen PY (2009) Advances in meningioma therapy. Curr Neurol Neurosci Rep 9:231\u2013240","journal-title":"Curr Neurol Neurosci Rep"},{"key":"127_CR3","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors (2007) WHO classification of tumours of the central nervous system, 4th edn. IARC Press, Lyons. pp 164\u2013172"},{"key":"127_CR4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","volume":"63","author":"K Lamszus","year":"2004","unstructured":"Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63:275\u2013286","journal-title":"J Neuropathol Exp Neurol"},{"key":"127_CR5","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ijrobp.2007.12.020","volume":"71","author":"D Pasquier","year":"2008","unstructured":"Pasquier D, Bijmolt S, Veninga T, Rezvoy N, Villa S, Krengli M et al (2008) Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network. Int J Radiat Oncol Biol Phys 71:1388\u20131393","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"127_CR6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","volume":"101","author":"O Al-Mefty","year":"2004","unstructured":"Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101:210\u2013218","journal-title":"J Neurosurg"},{"key":"127_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1054-3589(08)60669-9","volume":"33","author":"KK Wu","year":"1995","unstructured":"Wu KK (1995) Inducible cyclooxygenase and nitric oxide synthase. Adv Pharmacol 33:179\u2013207","journal-title":"Adv Pharmacol"},{"key":"127_CR8","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.271.52.33157","volume":"271","author":"WL Smith","year":"1996","unstructured":"Smith WL, Garavito RM, DeWitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157\u201333160","journal-title":"J Biol Chem"},{"key":"127_CR9","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","volume":"107","author":"CE Eberhart","year":"1994","unstructured":"Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183\u20131188","journal-title":"Gastroenterology"},{"key":"127_CR10","first-page":"3785","volume":"55","author":"H Sano","year":"1995","unstructured":"Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K et al (1995) Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 55:3785\u20133789","journal-title":"Cancer Res"},{"key":"127_CR11","first-page":"2556","volume":"55","author":"SL Kargman","year":"1995","unstructured":"Kargman SL, O\u2019Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S (1995) Expression of prostaglandin G\/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55:2556\u20132559","journal-title":"Cancer Res"},{"key":"127_CR12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00428-004-1105-2","volume":"445","author":"D Wendum","year":"2004","unstructured":"Wendum D, Masliah J, Trugnan G, Flejou JF (2004) Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch 445:327\u2013333","journal-title":"Virchows Arch"},{"key":"127_CR13","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.febslet.2006.03.075","volume":"580","author":"A Dekanty","year":"2006","unstructured":"Dekanty A, Giulianelli S, Coso OA, Rudland PS, Jimenez de Asua L (2006) Differential involvement of ERK1-2 and p38MAPK activation on Swiss 3T3 cell proliferation induced by prostaglandin F2alpha. FEBS Lett 580:2512\u20132516","journal-title":"FEBS Lett"},{"key":"127_CR14","doi-asserted-by":"crossref","first-page":"8921","DOI":"10.1073\/pnas.1533221100","volume":"100","author":"H Nishihara","year":"2003","unstructured":"Nishihara H, Kizaka-Kondoh S, Insel PA, Eckmann L (2003) Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2. Proc Natl Acad Sci USA 100:8921\u20138926","journal-title":"Proc Natl Acad Sci USA"},{"key":"127_CR15","doi-asserted-by":"crossref","first-page":"26176","DOI":"10.1074\/jbc.M313346200","volume":"279","author":"H Nishihara","year":"2004","unstructured":"Nishihara H, Hwang M, Kizaka-Kondoh S, Eckmann L, Insel PA (2004) Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1\/2 and p38 MAPK. J Biol Chem 279:26176\u201326183","journal-title":"J Biol Chem"},{"key":"127_CR16","first-page":"1741","volume":"9","author":"Y Miyata","year":"2003","unstructured":"Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H (2003) Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res 9:1741\u20131749","journal-title":"Clin Cancer Res"},{"key":"127_CR17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sj.bjc.6601534","volume":"90","author":"GP Boland","year":"2004","unstructured":"Boland GP, Butt IS, Prasad R, Knox WF, Bundred NJ (2004) COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ. Br J Cancer 90:423\u2013429","journal-title":"Br J Cancer"},{"key":"127_CR18","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3346\/jkms.2006.21.5.871","volume":"21","author":"YE Joo","year":"2006","unstructured":"Joo YE, Chung IJ, Park YK, Koh YS, Lee JH, Park CH et al (2006) Expression of cyclooxygenase-2, p53 and Ki-67 in gastric cancer. J Korean Med Sci 21:871\u2013876","journal-title":"J Korean Med Sci"},{"key":"127_CR19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","volume":"94","author":"MJ Thun","year":"2002","unstructured":"Thun MJ, Henley SJ, Patrono C (2002) Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252\u2013266","journal-title":"J Natl Cancer Inst"},{"key":"127_CR20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1146\/annurev.pharmtox.42.082301.164620","volume":"42","author":"LJ Marnett","year":"2002","unstructured":"Marnett LJ, DuBois RN (2002) COX-2: a target for colon cancer prevention. Annu Rev Pharmacol Toxicol 42:55\u201380","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"127_CR21","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891\u2013899","journal-title":"N Engl J Med"},{"key":"127_CR22","first-page":"S98","volume":"26","author":"CC Lin","year":"2003","unstructured":"Lin CC, Kenyon L, Hyslop T, Hammond E, Andrews DW, Curran WJ Jr et al (2003) Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade. Am J Clin Oncol 26:S98\u2013S102","journal-title":"Am J Clin Oncol"},{"key":"127_CR23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jcp.57.1.6","volume":"57","author":"N Nathoo","year":"2004","unstructured":"Nathoo N, Barnett GH, Golubic M (2004) The eicosanoid cascade: possible role in gliomas and meningiomas. J Clin Pathol 57:6\u201313","journal-title":"J Clin Pathol"},{"key":"127_CR24","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3748\/wjg.v18.i15.1793","volume":"18","author":"J Al-Maghrabi","year":"2012","unstructured":"Al-Maghrabi J, Buhmeida A, Emam E, Syrjanen K, Sibiany A, Al-Qahtani M et al (2012) Cyclooxygenase-2 expression as a predictor of outcome in colorectal carcinoma. World J Gastroenterol 18:1793\u20131799","journal-title":"World J Gastroenterol"},{"key":"127_CR25","first-page":"4064","volume":"6","author":"R Masunaga","year":"2000","unstructured":"Masunaga R, Kohno H, Dhar DK, Ohno S, Shibakita M, Kinugasa S et al (2000) Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6:4064\u20134068","journal-title":"Clin Cancer Res"},{"key":"127_CR26","doi-asserted-by":"crossref","first-page":"8221","DOI":"10.1158\/1078-0432.CCR-08-1841","volume":"14","author":"S Ogino","year":"2008","unstructured":"Ogino S, Kirkner GJ, Nosho K, Irahara N, Kure S, Shima K et al (2008) Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer. Clin Cancer Res 14:8221\u20138227","journal-title":"Clin Cancer Res"},{"key":"127_CR27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/jcp.55.6.429","volume":"55","author":"C Costa","year":"2002","unstructured":"Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC (2002) Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 55:429\u2013434","journal-title":"J Clin Pathol"},{"key":"127_CR28","first-page":"1315","volume":"27","author":"HP Dhakal","year":"2012","unstructured":"Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E et al (2012) Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact. Histol Histopathol 27:1315\u20131325","journal-title":"Histol Histopathol"},{"key":"127_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-9966-30-27","volume":"30","author":"F Li","year":"2011","unstructured":"Li F, Liu Y, Chen H, Liao D, Shen Y, Xu F et al (2011) EGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical features. J Exp Clin Cancer Res 30:27","journal-title":"J Exp Clin Cancer Res"},{"key":"127_CR30","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.3171\/FOC-07\/10\/E8","volume":"23","author":"C Pfister","year":"2007","unstructured":"Pfister C, Ritz R, Pfrommer H, Bornemann A, Tatagiba MS, Roser F (2007) Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas? Neurosurg Focus 23:E8","journal-title":"Neurosurg Focus"},{"key":"127_CR31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3171\/jns.2005.103.3.0508","volume":"103","author":"BT Ragel","year":"2005","unstructured":"Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2005) Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 103:508\u2013517","journal-title":"J Neurosurg"},{"key":"127_CR32","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.pai.0000201807.58801.fc","volume":"15","author":"AM Buccoliero","year":"2007","unstructured":"Buccoliero AM, Castiglione F, Rossi Degl\u2019Innocenti D, Arganini L, Taddei A, Ammannati F et al (2007) Cyclooxygenase-2 (COX-2) overexpression in meningiomas: real time PCR and immunohistochemistry. Appl Immunohistochem Mol Morphol 15:187\u2013192","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"127_CR33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cncr.22441","volume":"109","author":"BT Ragel","year":"2007","unstructured":"Ragel BT, Jensen RL, Gillespie DL, Prescott SM, Couldwell WT (2007) Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 109:588\u2013597","journal-title":"Cancer"},{"key":"127_CR34","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2011.2.FOCUS1117","volume":"30","author":"MH Pham","year":"2011","unstructured":"Pham MH, Zada G, Mosich GM, Chen TC, Giannotta SL, Wang K et al (2011) Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms. Neurosurg Focus 30:E7","journal-title":"Neurosurg Focus"},{"key":"127_CR35","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3171\/jns.2007.106.6.1034","volume":"106","author":"JS Smith","year":"2007","unstructured":"Smith JS, Lal A, Harmon-Smith M, Bollen AW, McDermott MW (2007) Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. J Neurosurg 106:1034\u20131040","journal-title":"J Neurosurg"},{"issue":"Suppl 1","key":"127_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1054\/jocn.2001.0877","volume":"8","author":"SY Yang","year":"2001","unstructured":"Yang SY, Xu GM (2001) Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas. J Clin Neurosci 8(Suppl 1):49\u201353","journal-title":"J Clin Neurosci"},{"key":"127_CR37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-004-5233-y","volume":"73","author":"EA Lusis","year":"2005","unstructured":"Lusis EA, Chicoine MR, Perry A (2005) High throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol 73:219\u2013223","journal-title":"J Neurooncol"},{"key":"127_CR38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1748-717X-5-46","volume":"5","author":"AG Wernicke","year":"2010","unstructured":"Wernicke AG, Dicker AP, Whiton M, Ivanidze J, Hyslop T, Hammond EH et al (2010) Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma. Radiat Oncol 5:46","journal-title":"Radiat Oncol"},{"key":"127_CR39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-009-9948-7","volume":"96","author":"AD Norden","year":"2010","unstructured":"Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM et al (2010) Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. J Neurooncol 96:211\u2013217","journal-title":"J Neurooncol"},{"key":"127_CR40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11060-011-0687-1","volume":"106","author":"DA Reardon","year":"2012","unstructured":"Reardon DA, Norden AD, Desjardins A, Vredenburgh JJ, Herndon JE 2nd, Coan A et al (2012) Phase II study of Gleevec (R) plus hydroxyurea (HU) in adults with progressive or recurrent meningioma. J Neurooncol 106:409\u2013415","journal-title":"J Neurooncol"},{"key":"127_CR41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1215\/15228517-2009-010","volume":"11","author":"PY Wen","year":"2009","unstructured":"Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE et al (2009) Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01\u201308). Neuro Oncol 11:853\u2013860","journal-title":"Neuro Oncol"},{"key":"127_CR42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11060-012-0886-4","volume":"109","author":"L Nayak","year":"2012","unstructured":"Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J et al (2012) Atypical and anaplastic meningiomas treated with bevacizumab. J Neurooncol 109:187\u2013193","journal-title":"J Neurooncol"},{"key":"127_CR43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11060-012-0861-0","volume":"109","author":"E Lou","year":"2012","unstructured":"Lou E, Sumrall AL, Turner S, Peters KB, Desjardins A, Vredenburgh JJ et al (2012) Bevacizumab therapy for adults with recurrent\/progressive meningioma: a retrospective series. J Neurooncol 109:63\u201370","journal-title":"J Neurooncol"},{"key":"127_CR44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10:181\u2013193","journal-title":"Nat Rev Cancer"},{"key":"127_CR45","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB et al (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946\u20131952","journal-title":"N Engl J Med"},{"key":"127_CR46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313\u20131316","journal-title":"N Engl J Med"},{"key":"127_CR47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","volume":"302","author":"AT Chan","year":"2009","unstructured":"Chan AT, Ogino S, Fuchs CS (2009) Aspirin use and survival after diagnosis of colorectal cancer. JAMA 302:649\u2013658","journal-title":"JAMA"},{"key":"127_CR48","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(11)61049-0","volume":"378","author":"J Burn","year":"2011","unstructured":"Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081\u20132087","journal-title":"Lancet"},{"key":"127_CR49","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","volume":"356","author":"AT Chan","year":"2007","unstructured":"Chan AT, Ogino S, Fuchs CS (2007) Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N Engl J Med 356:2131\u20132142","journal-title":"N Engl J Med"},{"key":"127_CR50","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.161.5.2441","volume":"161","author":"M Barrios-Rodiles","year":"1998","unstructured":"Barrios-Rodiles M, Chadee K (1998) Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages. J Immunol 161:2441\u20132448","journal-title":"J Immunol"},{"key":"127_CR51","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bbamcr.2007.09.001","volume":"1773","author":"T Klein","year":"2007","unstructured":"Klein T, Shephard P, Kleinert H, Komhoff M (2007) Regulation of cyclooxygenase-2 expression by cyclic AMP. Biochim Biophys Acta 1773:1605\u20131618","journal-title":"Biochim Biophys Acta"},{"key":"127_CR52","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.ajpath.2012.07.033","volume":"181","author":"PH Domingues","year":"2012","unstructured":"Domingues PH, Teodosio C, Ortiz J, Sousa P, Otero A, Maillo A et al (2012) Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Am J Pathol 181:1749\u20131761","journal-title":"Am J Pathol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-012-0127-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-012-0127-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-012-0127-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T21:30:53Z","timestamp":1687901453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-012-0127-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,19]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["127"],"URL":"https:\/\/doi.org\/10.1007\/s10014-012-0127-8","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,19]]}}}